Inaktiver Wert

Transkripte Cytori Therapeutics Inc Nasdaq

Aktien

US23283K4022

Transkripte

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Transcript : Plus Therapeutics, Inc., Q4 2023 Earnings Call, Mar 05, 2024	05.03.
Transcript : Plus Therapeutics, Inc. - Special Call	20.11.
Transcript : Plus Therapeutics, Inc., Q3 2023 Earnings Call, Oct 31, 2023	31.10.23
Transcript : Plus Therapeutics, Inc., Q2 2023 Earnings Call, Aug 14, 2023	14.08.23
Transcript : Plus Therapeutics, Inc., Q1 2023 Earnings Call, Apr 20, 2023	20.04.23
Transcript : Plus Therapeutics, Inc., Q4 2022 Earnings Call, Feb 23, 2023	23.02.23
Transcript : Plus Therapeutics, Inc., Q3 2022 Earnings Call, Oct 20, 2022	20.10.22
Transcript : Plus Therapeutics, Inc., Q2 2022 Earnings Call, Jul 21, 2022	21.07.22
Transcript : Plus Therapeutics, Inc., Q1 2022 Earnings Call, Apr 21, 2022	21.04.22
Transcript : Plus Therapeutics, Inc., Q4 2021 Earnings Call, Feb 24, 2022	24.02.22
Transcript : Plus Therapeutics, Inc. - Special Call	18.11.21
Transcript : Plus Therapeutics, Inc., Q3 2021 Earnings Call, Oct 21, 2021	21.10.21
Transcript : Plus Therapeutics, Inc., Q2 2021 Earnings Call, Jul 22, 2021	22.07.21
Transcript : Plus Therapeutics, Inc. - Shareholder/Analyst Call	17.05.21
Transcript : Plus Therapeutics, Inc., Q1 2021 Earnings Call, Apr 22, 2021	22.04.21
Transcript : Plus Therapeutics, Inc., Q4 2020 Earnings Call, Feb 22, 2021	22.02.21
Transcript : Plus Therapeutics, Inc. - Special Call	19.11.20
Transcript : Plus Therapeutics, Inc., Q3 2020 Earnings Call, Oct 22, 2020	22.10.20
Transcript : Plus Therapeutics, Inc., Q2 2020 Earnings Call, Aug 10, 2020	10.08.20
Transcript : Plus Therapeutics, Inc. - Shareholder/Analyst Call	16.06.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Transkripte Cytori Therapeutics Inc Nasdaq

Aktien

US23283K4022

Transkripte

Filter